NASDAQ
Fulgent Genetics, Inc. (FLGT) has a free cash flow growth of 102.28% as of Friday, May 29, 2026. This represents a 119.69% increase compared to its 12-month average of -519.38%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.